CARRIE MARGUET: Open Payments
NPI 1538248737 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 20 payments from 14 companies in 2025. Trend: 2023 $438 · 2024 $707 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $79 |
| ABBVIE INC. | 4 | $76 |
| Gilead Sciences, Inc. | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| TAIHO ONCOLOGY, INC. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| PFIZER INC. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Acrotech Biopharma Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
Products named: Trodelvy, TECVAYLI, IMBRUVICA, Fabhalta, LONSURF, Nubeqa, CREON, XTANDI.
Industry payments across SC — which companies pay providers there.
